Rarely, serious (sometimes fatal) asthma-related breathing problems may occur in people with asthma who are treated with drugs similar to formoterol (long-acting beta agonists). In people with asthma, this product should only be used when one long-term medication (such as inhaled corticosteroids) does not control breathing problems. Before using this medication, it is important to...
Read moreLast week, the Food and Drug Administration (FDA) listened to presentations and comments from several members of an expert FDA advisory... Read more »
In this entry, I would like to discuss some recent findings on two similar medications that have significantly changed the landscape of... Read more »
While the economy sputters, the long acting bronchodilator/ corticosteroid combination inhaler market is booming. While big ... Read more »
Last month the FDA (Food and Drug Administration) voted unanimously that the benefit of Advair and Symbicort outweighed the risks of... Read more »
It would be neat if asthma was like a sport. Instead of writing dry, humorless posts, we could write exciting and entertaining posts... Read more »
Data from a study comparing Symbicort (budesonide, formoterol), Advair (fluticasone propionate, salmeterol), and salbutamol has found that... Read more »
The Food and Drug Administration has approved a new combination treatment, Symbicort, for the treatment of asthma in people ages 12 and older.... Read more »
A new study has found that using Symbicort as both a preventative asthma medicine and as a "rescue" drug cuts asthma patients' risk of having severe... Read more »
A new medication that combines two effective asthma medications is now available in India. The drug, Avessa, combines the long-acting properties of... Read more »
British drugmaker AstraZeneca has launched the asthma med Symbicort in the United States. Symbicort combines the corticosteroid budesonide with... Read more »